Le Lézard
Classified in: Science and technology
Subjects: AWD, BFA, OBI

Krause Center for Innovation to recognize the late Julie Cates, engineer, advocate and philanthropist


LOS ALTOS HILLS, Calif., April 5, 2023 /PRNewswire/ -- The Krause Center for Innovation (KCI) is deeply saddened by the loss of long-time engineer and philanthropist Julie Cates, who passed away late last year. Cates was a beloved community member known for her extensive outreach and dedication to philanthropic organizations, especially those centering on the needs of at-risk youth, early education and innovation, like the KCI.

"Julie was there since the beginning," said KCI Executive Director Gay Krause. "When I founded the KCI in 2000, Julie was there to help. She was our first volunteer on the advisory board and generously donated her time and energy to us for the next 22 years."

Krause said Cates' impact on the KCI, particularly in its early years, could not be overstated.

"Julie pushed me to develop and contribute in more ways than I had thought possible. She would say, 'Gay, don't you think you should have a website? How about a mission statement? If you don't know how to write one, I'll do it with you.' And later that week, we met to accomplish those tasks."

Cates' legacy is one of a woman who was a tireless and passionate advocate for youth. The KCI would like to thank the Cates family for their generosity, which they have graciously extended toward the KCI even following their beloved Julie's passing. The KCI will recognize Julie and the Cates family at an award ceremony on May 11th and install a plaque in her memory within its facility.

Cates was a fourth-generation Californian, born and raised in Pasadena. She earned her bachelor's and master's degrees at Stanford University and went on to work at the Hewlett Packard site in Cupertino, where she met her husband, Fred Ware. They were married for 46 years and raised three sons.

SOURCE Krause Center for Innovation


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...



News published on and distributed by: